The company is pleased to announce the commencing of a new collaborative European project “diaRNAgnosis”. In the framework of the project, NanoGetic SL will join forces with the other Spanish company DESTINA Genomica SL and the Italian OPTOI Srl to develop reliable, innovative method and platform to identify cancer biomarkers in liquid biopsies. In this effort, the three companies will cooperate with three key academic research groups from the Universities of Trento and Catania (Italy), Granada (Spain); as well as the Princess Máxima Center (Nederland).

For further information about diaRNAgnosis, visit the brand-new website. Here you can also read an interview to the project coordinator.